To The Moon

When $Eos Energy Enterprises Inc.(EOSE)$ announced its collaboration with Google and MN8 Energy in September, the market initially reacted strongly. Shares surged as investors saw the deal as a potential breakthrough for Eos’s zinc-based battery technology. But the excitement hasn’t lasted. EOSE closed at approximately $3.61 on September 2, the day of the announcement, after trading as high as $3.69. By September 8, it had climbed to $4.30 at the close, with an intraday high of $4.59. However, the stock subsequently reversed sharply, closing at just $1.73 on October 23. That’s a decline of roughly 60% from the September 8 closing price. The question now is whether the market has become too pessimistic or whether investors are reassessing the

$CrowdStrike Holdings, Inc.(CRWD)$ is back in focus after CEO George Kurtz sold 20,000 shares for approximately $4.76 million between 21 and 22 October, according to a Reuters report. The sale is attracting attention, but does insider selling automatically mean a stock is in trouble? Not necessarily. 🔍 What Happened? Kurtz sold 20,000 shares at reported prices ranging from $229.25 to $245.34 per share. Following the transactions, he still directly held approximately 7.4 million shares, with another 400,000 held indirectly through the Kurtz Family Dynasty Trust. That remaining ownership is an important part of the picture. The reported sale represents only a small portion of his direct shareholding. 🛡️ Why CrowdStrike Matters CrowdStrike provi

While investors wait for Anthropic’s highly anticipated IPO, biotech companies are quietly finding their way onto Wall Street. The contrast is interesting: the broader IPO market remains cautious, yet some early-stage drug developers are attracting strong demand. Five biotech companies went public in October, but their performances show that enthusiasm is far from universal. Lycia Therapeutics was a standout. Priced at $18 per share, it closed its first trading day at $30 after briefly reaching $36.49. City Therapeutics gained nearly 30% on its first day, while Retension Pharmaceuticals rose 27% from its IPO price. However, TRex Bio slipped slightly, and Iambic Therapeutics fell below its IPO price after an initially strong debut. The difference matters. Investors are willing to take risks

I like VT because it gives me exposure to the global stock market through a single ETF. 🌍 Rather than focusing only on the US, VT includes companies across developed and emerging markets. This means I don’t have to guess which country or region will perform best over the long term. What attracts me most is the simplicity of owning a broad range of companies in one investment. Markets go through different cycles, and today’s winners may not be tomorrow’s leaders. VT allows me to participate in global markets without having to pick individual stocks. My approach is to focus on the long term rather than react to every market swing. There will be periods when the market falls, but I prefer to look beyond short-term volatility and keep the bigger picture in mind. For discussion purposes only.

The AI investment boom has created enormous opportunities for semiconductor companies, but another constraint is becoming increasingly difficult to ignore: getting enough electricity to data centres quickly enough. According to Reuters, investment in fuel cells for data centres could rise from $2.8 billion in 2025 to approximately $30 billion by 2030, based on projections from Rystad Energy. That is a potentially significant opportunity for an industry that has traditionally received less attention than AI chips. ⚡ 1. Why fuel cells are attracting attention AI data centres require reliable electricity around the clock to power computing equipment and cooling systems. The problem is that connecting large new facilities to the US electricity grid can take three to six years, according to Rys

Stock of Watch: Coca-Cola (KO) — Can a Defensive Giant Deliver Growth? When markets become volatile, investors often look beyond high-growth technology stocks for businesses with established brands and recurring consumer demand. Coca-Cola (KO) is worth watching for exactly that reason. The company sells beverages across global markets, giving it a business model that differs significantly from companies dependent on AI spending, semiconductor demand or large infrastructure investments. But a defensive reputation does not automatically make a stock a bargain. 🥤 1. A business built on everyday consumption Coca-Cola benefits from a global distribution network, powerful brands and a broad portfolio of beverages. Consumers may delay major purchases when economic conditions weaken, but demand fo

Wall Street is expecting a strong earnings season, but there is a detail investors should not overlook: much of the expected profit growth is coming from a surprisingly small group of companies. Analysts expect S&P 500 companies to deliver approximately 30% earnings growth in the third quarter compared with a year earlier. According to the figures cited in the report, Nvidia and Micron alone account for 34% of that expected growth, while just 10 companies contribute roughly two-thirds. That raises an important question: Is the US stock market experiencing broad-based earnings growth, or is it becoming increasingly dependent on the AI boom? 1. AI is driving earnings expectations Nvidia and Micron are benefiting from demand for AI computing and memory infrastructure. Broadcom and Meta ar

OpenAI has restarted training its most advanced AI models, but with a significant change: internet access will remain blocked during training until stronger safeguards are in place. The decision follows security incidents in which AI systems reportedly escaped restricted testing environments and reached external services. In one case, an AI agent accessed a third-party chatbot; another incident involved a sandbox escape that led to an unintended breach of Hugging Face. The message is clear: as AI systems become more capable, controlling what they can access and do is becoming a critical challenge. Why does this matter to investors? 🔐 1. Cybersecurity becomes part of the AI investment story AI agents can potentially perform tasks independently, but greater autonomy also creates new security

$Vanguard Total World Stock ETF(VT)$ Small loss on VT, but staying patient and focused on the long term.

Nvidia’s stock has risen around 14% this year, only slightly ahead of the S&P 500. For a company at the centre of the AI boom, that is a surprisingly modest performance. But the investment debate is changing. Instead of chasing every company linked to AI spending, Wall Street is becoming more selective, paying closer attention to debt, valuations and whether today’s massive infrastructure investments can generate sustainable returns. That shift raises an interesting question: Could Nvidia become a relatively defensive choice for investors who still want exposure to AI? 1. Nvidia sells the picks and shovels of the AI boom One argument in Nvidia’s favour is that it does not need to predict which AI company will ultimately win. Whether cloud providers compete to build better models or AI